Excellos is a developer and manufacturer of cell, gene therapies.
Excellos's investors include Telegraph Hill Partners, Vitalant.
Excellos is headquartered in San Diego, United States.
Excellos is a developer and manufacturer of cell, gene therapies.
Excellos is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Excellos — Funding & Investors." VCBacked, January 17, 2024, https://www.vcbacked.co/company/excellos. Accessed August 15, 2026.
VCBacked. (2024). Excellos — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/excellos
{{cite web |title=Excellos — Funding & Investors |url=https://www.vcbacked.co/company/excellos |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated